DRUGS MADE IN AMERICA ACQUISITION II CORP.: sga_expense
| Value | {"amount": 132030, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-03-31 |
| Status | current |
| Entity | DRUGS MADE IN AMERICA ACQUISITION II CORP. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:07:31.882959+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4b5cb292-da59-4b0e-b40c-02cb8faf5b68
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-056651Retrieved: 2026-08-19T19:07:31.882959+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0002040475/sga-expense/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4b5cb292-da59-4b0e-b40c-02cb8faf5b68
History
- no predecessors — first report